
TerriConneran
@terriconneran
T like Trouble @KRASKickers
Too spunky for #LungCancer
Kicking cancer’s #KRAS #research #advocate #survivor
#hope ❤️🤣🙏#biomarker
NO #KRASholes
ID: 1330538180240691202
http://www.KRASKickers.org 22-11-2020 15:49:22
2,2K Tweet
1,1K Followers
888 Following

#lungcancer #lcsm KRASKickers #kras FLASCO OLACANCER Memorial Cancer Institute Memorial Healthcare System


From the February issue: The Evolutionary Forest of #PancreaticCancer aacrjournals.org/cancerdiscover… By Katelyn Mullen, Ben Raphael, Chris Iacobuzio, and colleagues. MSKCC Center for Pancreatic Cancer Research Memorial Sloan Kettering Cancer Center



Thanks to KRASKickers for te opportunity to discuss about biomarkers with their community! Thanks TerriConneran for the fantastic discussion! Testing Testing Testing! The James Ohio State Medical Oncology International Society of Liquid Biopsy



Congratulations to Sandra Misale, PhD, recipient of the 2025 Cancer Discovery Early Career Award, which recognizes the outstanding contributions of #earlycareer investigators. Learn more: brnw.ch/21wSfdp #AACR25 Johns Hopkins Medicine Johns Hopkins Kimmel Cancer Center AACR



Dr Shokat talk at opening plenary at #AACR25 on how progress in studying #KRAS, historically known as ‘undruggable’, led to developing drugs to target it. Never say never… The impossible CAN be possible! KRASKickers #LCSM


#AACR25 session today ND01 - AMG 410: An H/NRAS-sparing pan-KRAS inhibitor with dual GTP(on)/GDP(off)-state activity for the treatment of diverse KRAS-mutant tumors A FIH study with AMG 410 is planned CRC, PDAC, NSCLC) G12D, G12V, G13D abstractsonline.com/pp8/#!/20273/p… KRASKickers


conclusion slide many slides of interest including KRAS targets & their responses as well as combinatorial options (EGFRi & anti-PD-1) KRASKickers #AACR25



Christine Lovly, MD, PhD, FASCO AACR IASLC Very exciting early signals for JYP0322 at #AACR25 — especially promising that no DLTs were observed and MTD wasn't reached during dose escalation. Also interesting that patients with stable CNS metastases were eligible — curious to see more on intracranial outcomes as data

SY08 - Developments in RAS Signaling Inhibition: Bench to Bedside Frank McCormick! Piro Lito! Sandra Misale! abstractsonline.com/pp8/#!/20273/s… KRASKickers Sandra Misale


So proud of you & the #KickKRAS progress you’re making!! KRASKickers

Online now concurrent with the #AACR25 oral presentation by Cancer Discovery Early Career Award Winner Sandra Misale: Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations brnw.ch/21wSh8j



Advances in ctDNA assays enhance early relapse detection in lung cancer — sessions at #ASCO25 will showcase these data and I look forward to seeing the updates on MRD! Penn Medicine MD Penn Medicine Penn Medicine - Abramson Cancer Center ASCO OncoAlert Martin Reck

